Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.

Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA

Volumn 22, Issue 6, 2002, Pages 524-526

  Lu, Wei ^a   Li, Yan Hao ^a   He, Xiao Feng ^a   Chen, Yong ^a   Zeng, Qing Le ^a   Qiu, Yu Rong ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; EPIRUBICIN; MITOMYCIN;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; T-LYMPHOCYTE SUBSETS;

EID: 0036615246     PISSN: 10002588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)